Endo, Inc.

Mallinckrodt and Endo are now set to complete their merger by early August, after a ruling from the Irish High Court removed one of the final obstacles to the firms consummating the combination. Annou

As Endo gears up to consummate its $6.7bn merger with Mallinckrodt later this year, the firm has completed the divestment of its International Pharmaceuticals business – primarily operated through Can

As Mallinckrodt and Endo continue to work towards merging their businesses, the firms have revealed further details of their plans for the combined company’s generics and sterile injectables unit, whi

Biopharma merger and acquisition value for the first quarter of 2025 reached $38.4bn from 41 transactions, 22 of which had disclosed values. Making up almost 38% of that total was Johnson & Johnso